DNA RNA and Cells

10 Jun 2009 Amarin Announces Results from Exploratory Phase 2a Study of EN101 in Myasthenia Gravis
09 Jun 2009 Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
08 Jun 2009 StemCells, Inc. Announces Positive Phase I Batten Trial Results
08 Jun 2009 Alnylam and Cubist Report Preliminary Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
08 Jun 2009 MDRNA, Inc. Reports Effective Local Delivery of a UsiRNA in an In Vivo Model of Bladder Cancer
08 Jun 2009 Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
08 Jun 2009 NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer
04 Jun 2009 LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
28 May 2009 Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
27 May 2009 Cytori Completes Enrollment in First Adipose Stem & Regenerative Cell Therapy Trial for Chronic Heart Disease
27 May 2009 Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease
27 May 2009 International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells
22 May 2009 Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
20 May 2009 Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
19 May 2009 MDRNA Reports Its Proprietary RNAi-Based Compounds Are Well Tolerated and Demonstrate High Potency Against Multiple Targets in Preclinical Studies
19 May 2009 Sylentis presents new data on its compounds for the treatment of Glaucomas and Dry Eye Syndrome at ARVO Congress
18 May 2009 Altair Therapeutics Reports Successful Completion of Phase I Study of Inhaled AIR645
18 May 2009 MOLOGEN AG: Positive preliminary results onclinical trial with anti-cancer drug
14 May 2009 Regulus Therapeutics Achieves Initial Milestone in its Inflammatory Diseases Collaboration with GlaxoSmithKline
14 May 2009 Mesoblast Limited (ASX:MSB) Announce Heart Muscle Function Improved Significantly After Single, Lowest-Dose Injection Of "Off-The-Shelf" Stem Cells In
13 May 2009 Cellerant Therapeutics Announces Dosing of First Patient in a Phase 1 Trial of CLT-008 for Hematological Malignancies
12 May 2009 Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
11 May 2009 Idera Pharmaceuticals Announces Presentation of Preclinical Data on IMO-3100, a Lead TLR Antagonist Drug Candidate for Autoimmune Diseases, during American Association of Immunologists Annual Meeting
11 May 2009 Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3
11 May 2009 Roche Partners With Tekmira Pharmaceuticals to Advance RNAi Product Candidates

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up